Abstract:Most episodes of acute heart failure (AHF) are characterized by increasing signs and symptoms of congestion, manifested by edema, pleura effusion and/or ascites. Immediately and repeatedly administered intravenous (IV) loop diuretics currently represent the mainstay of initial therapy aiming to achieve adequate diuresis/natriuresis and euvolemia. Despite these efforts, a significant proportion of patients have residual congestion at discharge, which is associated with a poor prognosis. Therefore, a standardized approach is needed. The door to diuretic time should not exceed 60 min. As a general rule, the starting IV dose is 20–40 mg furosemide equivalents in loop diuretic naïve patients or double the preexisting oral home dose to be administered via IV. Monitoring responses within the following first hours are key issues. (1) After 2 h, spot urinary sodium should be ≥50–70 mmol/L. (2) After 6 h, the urine output should be ≥100–150 mL/hour. If these target measures are not reached, the guidelines currently recommend a doubling of the original dose to a maximum of 400–600 mg furosemide per day and in patients with severely impaired kidney function up to 1000 mg per day. Continuous infusion of loop diuretics offers no benefit over intermittent boluses (DOSE trial). Emerging evidence by recent randomized trials (ADVOR, CLOROTIC) supports the concept of an early combination diuretic therapy, by adding either acetazolamide (500 mg IV once daily) or hydrochlorothiazide. Acetazolamide is particularly useful in the presence of a baseline bicarbonate level of ≥27 mmol/L and remains effective in the presence of preexisting/worsening renal dysfunction but should be used only in the first three days to prevent severe metabolic disturbances. Patients should not leave the hospital when they are still congested and/or before optimized long-term guideline-directed medical therapy has been initiated. Special attention should be paid to AHF patients during the vulnerable post-discharge period, with an early follow-up visit focusing on up-titrate treatments of recommended doses within 2 weeks (STRONG-HF).

Extracorporeal veno-venous ultrafiltration in congestive heart failure: What’s the state of the art? A mini-review

Development of a new miniaturized system for ultrafiltration

Early continuous ultrafiltration in Chinese patients with congestive heart failure (EUC-CHF): study protocol for an open-label registry-based prospective clinical trial.

Diuretics and Ultrafiltration in Heart Failure

Diuretic-resistant heart failure and the role of ultrafiltration: A proposed protocol

Ultrafiltration Versus Intravenous Diuretics in Decompensated Heart Failure: a Meta-Analysis of Randomized Controlled Trials

The Art of Ultrafiltration, from Pump to Peritoneum

Ultrafiltration in critically ill patients treated with kidney replacement therapy

Decongestion (instead of ultrafiltration?)

Fluid Overload and Precision Net Ultrafiltration in Critically Ill Patients

Cutting the Gordian knot of diuretic resistance using continuous ultrafiltration in a Holt-Oram patient with decompensated heart failure and Eisenmenger syndrome: a case report

New Miniaturized System for Ultrafiltration: Rationale and Design of a Single-Center, Crossover, Randomized, Open-Label, Pilot Study Protocol

Decongestion in Acute Heart Failure—Time to Rethink and Standardize Current Clinical Practice?

Ultrafiltration in acute heart failure syndrome:a Meta-analysis

Proximal versus distal diuretics in congestive heart failure

Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial

Contemporary Decongestive Strategies in Acute Heart Failure

Ultrasound unveiling: Decoding venous congestion in heart failure for precision management of fluid status

UNLOADING STRATEGIES IN ADVANCED HEART FAILURE: THE ROLE OF POINT–OF–CARE ULTRASOUND

Comprehensive and Safe Decongestion in Acutely Decompensated Heart Failure

Ultrasound guidance for volume management in patients with heart failure